There is no single gold-standard test to diagnose Cushing's syndrome. Current standard practice relies on the low-dose dexamethasone suppression test (LDDST). It has been proposed, however ...

Concomitant medication can contribute to the diagnostic inaccuracy of the combined dexamethasone–corticotropin-releasing hormone (CRH) test in Cushing syndrome. The ability to differentiate ...

An anti-inflammatory drug called dexamethasone has been hailed as a ground-breaking treatment for hospital patients seriously ill with Covid-19. A UK trial showed the drug could save lives - the ...

Dexamethasone provided 4 mg at every 6 hours ... To verify HPA axis recovery, the rapid ACTH stimulation test may also be utilized. A synthetic analog of ACTH, cosyntropin 0.25 mg is administered ...

Remdesivir plus dexamethasone vs dexamethasone alone reduces the risk of mortality among patients hospitalized with COVID-19.